NY Times: “Is a Pill Enough to Fight H.I.V?” A dynamic debate about PrEP

New federal guidelines urge gay men and others who have unprotected sex to take a daily dose of the drug Truvada, a regimen called pre-exposure prophylaxis (PrEP), to curb H.I.V. infections and AIDS.

Is promoting the use of the antiviral drug a good public health strategy, or will it encourage more to have unprotected sex?

Click here to view full article